Diabetic neuropathy is difficult to treat in-spite new compound of drugs and high risk for foot ulceration and may be limb amputation. So far, there is no satisfactory treatment protocol to prevent or cure these disorders. Diabetic neuropathy is characterized by reduction of vascularity in peripheral nerves and deficiency in neurotrophic and angiogenic factors. Mesenchymal stem cells (MSC) were isolated from the inguinal adipose tissue of rats, and a streptozotocin-induced diabetic mice model of diabetic neuropathy. This study showed that MSC significantly promoted the level of antioxidant and the expression of antiapoptotic proteins, while lowering the expression of apoptotic proteins. The end results data showed evidence that stem cell therapy of diabetic nephropathy differentiated from adipose tissue stem cell (ADSC) is a feasible and inexpensive therapy.
Keywords: Diabetic neuropathy; Diabetes; Mesenchymal stem cell
Copyright © 2017 by The American Society for BioMedicine and BM-Publisher, Inc.
- Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Madani SP, Heshmat R, Larijani B. The Prevalence of Diabetic Peripheral Neuropathy and Related Factors. Iranian Journal of Public Health 2007;40;55-62.
- Musina RA, Belyavski AV, Tarusova OV, Solovyova EV, Sukhikh GT. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull Exp Biol Med 2008;145:539-543. [PubMed]
- Steigman SA, Fauza DO. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr Protoc Stem Cell Biol 2007;Chapter 1:Unit 1E.2. [PubMed]
- Tirino V, Paino F, d'Aquino R, Desiderio V, De Rosa A, Papaccio G. Methods for the identification, characterization and banking of human DPSCs: current strategies and perspectives. Stem Cell Rev 2011;7:608-615. [PubMed]
- Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell2002;13:4279-4295. [PMC free article] [PubMed]
- Zannettino AC, Paton S, Arthur A, et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008;214:413-421. [PubMed]
- Volarevic V, Arsenijevic N, Lukic ML, Stojkovic M. Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells 2011;29:5-10. [PMC free article] [PubMed]
- Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. the International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317. [PubMed]
- Uccelli A, Pistoia V, Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 2007;28:219-226. [PubMed]
- Shi Y, Hu G, Su J, et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res 2010;20:510-518. [PubMed]
- Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2011;2:34. [PMC free article] [PubMed]
- Duffy MM, Pindjakova J, Hanley SA, et al. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol 2011;41:2840-2851. [PubMed]
- Sullivan C, Murphy JM, Griffin MD, et al. Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis. Arthritis Res Ther 2012;14:R167. [PMC free article] [PubMed]
- Sullivan C, Barry F, Ritter T, et al. Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig. Stem Cells Dev 2013;22:3203-3213. [PMC free article][PubMed]
- Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin‐10 and the interleukin‐10 receptor. Annu Rev Immunol 2001;19:683-765. [PubMed]
- Kalampokis I, Yoshizaki A, Tedder TF. IL‐10‐producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013;15(Suppl 1):S1. [PubMed]
- Fleetwood AJ, Lawrence T, Hamilton JA, et al. Granulocyte‐macrophage colony‐stimulating factor (CSF) and macrophage CSF‐dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 2007;178:5245-5252. [PubMed]
- Xu W, Wang X, Xu G, et al. Light‐induced retinal injury enhanced neurotrophins secretion and neurotrophic effect of mesenchymal stem cells in vitro. Arq Bras Oftalmol 2013;76:105-110. [PubMed]
- Zhang H, Issekutz AC. Growth factor regulation of neutrophil‐endothelial cell interactions. J Leukoc Biol 2001;70:225-232. [PubMed]
- Andreassen CS, Jakobsen J, Flyvbjerg A, et al. Expression of neurotrophic factors in diabetic muscle–relation to neuropathy and muscle strength. Brain 2009;132:2724-2733. [PubMed]
- Kang TH, Moon E, Hong BN, et al. Diosgenin from Dioscorea nipponica ameliorates diabetic neuropathy by inducing nerve growth factor. Biol Pharm Bull 2011;34:1493-1498. [PubMed]
- Unger JW, Klitzsch T, Pera S, et al. Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord. Exp Neurol 1998;153:23-34. [PubMed]
- Prencipe G, Minnone G, Strippoli R, et al. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA. J Immunol 2014;192:3345-3354. [PubMed]
- Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217-1281. [PubMed]
- Guimarães ET, Cruz GDS, Farias de Almeida T, et al. Transplantation of stem cells obtained from murine dental pulp improves pancreatic damage, renal function, and painful diabetic neuropathy in diabetic type 1 mouse model. Cell Transplant 2013;22:2345-2354. [PubMed]
- Kim H, Han JW, Lee JY, et al. Diabetic mesenchymal stem cells are ineffective for improving limb ischemia due to their impaired angiogenic capability. Cell Transplant 2014;8:8. [PMC free article] [PubMed]
- Nakamura N, Naruse K, Kobayashi Y, et al. High glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt. J Diabetes Investig 2011;2:262-270. [PMC free article][PubMed]
- Cova L, Armentero MT, Zennaro E, et al. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res 2010;1311:12-27. [PubMed]
- Xia N, Xu JM, Zhao N, Zhao QS, Li M, Cheng ZF. Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats. Neurosci Lett 2015;597:84-89. [PubMed]
- Koh SH, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008;1229:233-248. [PubMed]
- Hata M, Omi M, Kobayashi Y, et al. Transplantation of cultured dental pulp stem cells into the skeletal muscles ameliorated diabetic polyneuropathy: therapeutic plausibility of freshly isolated and cryopreserved dental pulp stem cells. Stem Cell Res Ther 2015;6:162. [PMC free article] [PubMed]
- Reid AJ, Sun M, Wiberg M, Downes S, Terenghi G, Kingham PJ. Nerve repair with adipose-derived stem cells protects dorsal root ganglia neurons from apoptosis. Neuroscience 2011;199:515-522. [PubMed]
- Koci Z, Turnovcova K, Dubsky M, et al. Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia. Cell Biochem Funct 2014;32:597-604. [PubMed]
- Park HJ, Lee PH, Bang OY, Lee G, Ahn YH. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008;107:141-151. [PubMed]
- Edalatmanesh MA, Bahrami AR, Hosseini E, Hosseini M, Khatamsaz S. Neuroprotective effects of mesenchymal stem cell transplantation in animal model of cerebellar degeneration. Neurol Res 2011;33:913-920. [PubMed]
- Kim H, Kim JJ, Yoon YS. Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves. Endocr Metab Immune Disord Drug Targets 2012;12:168-178. [PMC free article] [PubMed]
READ THE FULL ARTICLE
1. Access this article through OpenAthens
3. Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Use the coding below to purchase your article as PDF by credit card, debit card, will be asked to supply your billing card information. Before continue with your purchase please read carefully the BM-Publisher terms and conditions of purchase.
For any technique error please contact us and will be response to sending purchase article by email.
Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...
Thank you for visiting American Journal of BioMedicine. * = Required fields
[contact-form-7 404 "Not Found"]
American Journal of BioMedicine Volume 5, Issue 3, pages 132-145
Received December 11, 2016; accepted February 22, 2017; published March 18, 2017
How to cite this article
Shi X, Shou K, Shi SH, Lee J. Stem cells from diabetic patients improve diabetic neuropathy" style. American Journal of BioMedicine 2017;5(3):132-145.